CRISPR/Cas9 technology generated a C to G change resulting in a phenylalanine to leucine substitution at amino acid 218 (p.F218L). This is equivalent to the human p.F234L pathogenic variant identified in a Pakistani family with Goldenhar syndrome (craniofacial microsomia). (J:336768)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count